Lantern Pharma Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Lantern Pharma Inc.
Quantité totale PI 72
Rang # Quantité totale PI 19 075
Note d'activité PI 2,7/5.0    55
Rang # Activité PI 13 020
Symbole boursier LTRN (nasdaq)
ISIN US51654W1018
Capitalisation 42.90M  (USD)
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

20 6
16 3
23 4
0
 
Dernier brevet 2025 - Combination of dimesna and pemet...
Premier brevet 1998 - Mercaptans and disulfides
Dernière marque 2025 - PREDICTBBB
Première marque 2019 - LANTERN PHARMA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Software as a service (SaaS) services featuring non-downloadable software that uses artificial-in...
Invention Method for treating breast cancers and parp resistant breast cancers. A method of treating breas...
2024 Invention Combination of dimesna and pemetrexed to treat non-small cell lung cancer (nsclc). A method of tr...
Invention Treating cancers with combinations of acylfulvenes with ibrutinib and/or bortezomib. A method of...
Invention Lyophilized hydroxyureamethyl acylfulvene. Lyophilized preparations include illudins, including h...
Invention Computerized systems and methods for ensemble model-based drug discovery. Disclosed are systems ...
Invention Treating liver cancers with hydroxyureamethyl acylfulvene. A method for treating liver cancer, pa...
Invention Treating cancers with combinations of anti-cd20 antibody and acylfulvenes. A method of treating c...
Invention Method for treating cancer with acylfulvene and radiation. The methods include treating cancer b...
Invention Machine learning system and method for predicting blood brain barrier permeability. A machine lea...
Invention Method for treating renal cell carcinoma or cancer. This method involves treating individuals dia...
Invention Treating cancers with combinations of spironolactone and acylfulvenes. A method of treating canc...
Invention Treating cancers with combinations of parp inhibitor and acylfulvenes. A method of treating canc...
2023 Invention Method for treating blood cancers. A method for treating a subject in need thereof having a bone...
Invention Illudin analogs, uses thereof, and methods for synthesizing the same. This invention provides il...
Invention Method for treating breast cancers and parp resistant breast cancers. A method of treating breast...
Invention Treatment of brain metastases and cns metastases using illudins or hydroxylureamethyl acylfulvene...
Invention Treating cancers with combinations of acylfulvenes with ibrutinib or bortezomib. A method of trea...
Invention Cancer drug sensitivity determining markers. This application relates to markers for use in the ...
Invention Computerized systems and methods for ensemble model-based drug discovery. Disclosed are systems a...
2022 Invention Method for treating cancer with acylfulvene and radiation. The methods include treating cancer by...
Invention Increasing cancer patient survival time by administration of dithio-containing compounds. The pr...
Invention Treating cancers with combinations of spironolactone and acylfulvenes. A method of treating cance...
Invention Treating cancers with combinations of parp inhibitor and acylfulvenes. A method of treating cance...
P/S Pharmaceutical preparations, namely, medications used in chemotherapeutic regimens for the treatm...
Invention Method for determining sensitivity to 2,2'-dithio-bis-ethane sulfonate. A method for treating ca...
Invention Method for treating blood cancers. A method for treating a subject in need thereof having a bone ...
Invention Method for treating lung cancer and non-small cell lung cancer. A method of treating NSCLC or lun...
P/S Drug discovery services; pharmaceutical research and development services in the field of oncolo...
2021 Invention Method for treating rhabdoid tumors. The methods include treating atypical teratoid/rhabdoid tumo...
Invention Cancer drug sensitivity determining markers. This application relates to markers for use in the d...
Invention Method for treating female non-smokers with non-small cell lung cancer. A method of treating a f...
P/S Drug discovery services; pharmaceutical research and development services in the field of oncolog...
Invention Method for treating pancreatic cancer. Methods for treating pancreatic cancer by administration ...
Invention Method for treating pancreatic cancer. Methods for treating pancreatic cancer by administration h...
Invention Methods for the treatment of solid tumor cancers using illudins and biomarkers. Methods for dete...
Invention Hydroxyureamethyl-acylfulvene for treating brain cancer or cns cancer. Methods for treating brai...
Invention Hydroxyureamethyl-acylfulvene for treating brain cancer or cns cancer. Methods for treating brain...
Invention Illudin analogs, uses thereof, and methods for synthesizing the same. This invention provides ill...
Invention Method for determining sensitivity to 2,2'-dithio-bis-ethane sulfonate. A method for treating can...
2020 P/S Pharmaceutical drug development services; pharmaceutical research and development services in the...
P/S drug discovery services; pharmaceutical research and development services in the field of oncolog...
Invention Method for treating female non-smokers with non-small cell lung cancer. A method of treating a fe...
2019 Invention Methods for the treatment of solid tumor cancers using illudins and biomarkers. Methods for deter...
2015 Invention Increasing cancer patient survival time by administration of dithio-containing compounds. The pre...
2014 Invention Contemporaneous, heterogeneously-oriented, multi-targeted therapeutic modification and/or modulat...
2008 Invention Compositions and methods of use of compounds to increase cancer patient survival time. The presen...
2007 Invention Compounds and methods for reducing undesired toxicity of chemotherapeutic agents. Novel compositi...